A study published in Stem Cell Reports demonstrates that genetically engineered human pluripotent stem cells (hPSCs) can ...

A Parkinson's disease treatment based on induced pluripotent stem cells (iPS) has been officially approved in Japan – as announced by ...

The International Society for Stem Cell Research (ISSCR) is pleased to announce Stem Cell COREdinates and CorEUstem as the ...

Conditional approval marks a global milestone in regenerative medicine; treatments could reach patients this summer - Anadolu ...

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...

The Japanese government on Friday conditionally approved the commercialization of two regenerative medicine products prepared from induced pluripotent ...

A team led by University of Osaka researchers has developed a technique to generate testes from mouse embryonic stem cells ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

Stem cell-derived endothelial cell differentiation represents a rapidly advancing field that leverages the plasticity of pluripotent cells to generate functional vascular components. Central to the ...

The International Society for Stem Cell Research (ISSCR) is pleased to announce that Alexander Meissner, Director at the Max ...